Medical Hypotheses
Volume 56, Issue 6 , Pages 648-652 , June 2001

Suppression of immune surveillance in melanoma

Received 27 June 2000 ,Accepted 5 September 2000.

References 

    REFERENCES
  1. O’Hara RM. Jr Antigen-specific suppressor factor: missing pieces in the puzzle. Immunol Res. 1995;14:252–262
  2. Wojtowicz-Praga S. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunotherapy. 1997;20:165–177
  3. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991–1045
  4. Becker JC, Czerny C, Brocker EB. Maintenance of clonal anergy by endogenously produced IL-10. International Immunol. 1994;6:1605–1612
  5. Constant SL, Bottomly K. Induction of the TH1 and TH2 CD4+ T cell responses. Annu Rev Immunol. 1997;15:297–322
  6. Y. CQ, Hong J, Tejada-Simon MV, Li S, Rivera VM, Killian JM, et al. Th2 immune regulation induced by T-cell vaccination in patients with multiple sclerosis. Eur J Immunol. 2000;30:908–913
  7. Jackson AL, Loeb LA. The mutation rate and cancer. Genetics. 1998;148:1483–1490
  8. Santambrogio L, Sato AK, Carven GJ, Belyanskaya SL, Strominger JL, Stern LJ. Extracellular antigen processing and presentation by immature dendritic cells. Proc Natl Acad Sci USA. 1999;96:15056–15061
  9. Santambrogio L, Sato AK, Fisher FR, Dorf ME, Stern LJ. Abundant empty class II MHC molecules on the surface of immature dendritic cells. ProcNatl Acad Sci USA. 1999;96:15050–15055
  10. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nature Medicine. 1999;12:1365–1369
  11. Chaux P, Favre N, Bonnotte B, Mouter M, Martin M, Martin F, et al. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression. Dendritic Cells in Fundamental and Clinical Immunology. NY: Plenum Press; 1997; p. 525–528
  12. Biggs MW, Eiselein JE. Observations on the treatment of autochthonous tumors in mice with an enterovirus and cyclophosphamide. Cancer Letters. 1993;69:133–137
  13. Eiselein JE, Biggs MW, Walton J. Treatment of transplanted murine tumors with an oncolytic virus and cyclophosphamide. Cancer Research. 1978;38:3817–3822
  14. Estrin M, Smith C, Huber S. Antigen-specific suppressor T-cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of Coxsackievirus group B, type 3. Am J Pathol. 1986;125:578–584
  15. Biggs, M. W. Eiselein, J. E. Immunotherapy of metastatic melanoma by reversal of immune suppression. 1997, UCRL- ID-125830, Lawrence Livermore National Laboratory, Livermore, Ca

PII: S0306-9877(00)91211-8

doi: 10.1054/mehy.2000.1211

Medical Hypotheses
Volume 56, Issue 6 , Pages 648-652 , June 2001

Article Tools